Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors

Sponsor
Mattias Block (Other)
Overall Status
Completed
CT.gov ID
NCT01764542
Collaborator
(none)
56
1
1
60
0.9

Study Details

Study Description

Brief Summary

The purpose of this study is to study development of dysplasia in the ileal mucosa among patients with Ulcerative Colitis and who previous have hade risk factors for developing cellular changes/dysplasia, i.e. previous dysplasia and/or carcinoma in their specimen.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopy and biopsy
N/A

Detailed Description

Objective Some of the rare complications reported in patients with an ileal pouch-anal anastomosis (IPAA) after colectomy for chronic ulcerative colitis are dysplasia and carcinoma. The supposed pathway is for the ileal pouch mucosa to go through adaptational changes then to progress through the phases of chronic pouchitis, dysplasia and subsequently to adenocarcinoma. The purpose of this study is to study development of dysplasia in the ileal mucosa among patients with Ulcerative Colitis and who previous have hade risk factors for developing cellular changes/dysplasia, i.e. previous dysplasia and/or carcinoma in their specimen.

Methods In a cohort of 680 patients having IPAA with a median follow-up time of 18 years, 75 patients with risk factors for dysplasia were identified. Sixty-five patients were eligible for inclusion, fifty-six patients accepted to participate in the study. Patients are invited for clinical examination, endoscopy with macroscopic evaluation as well as mucosal biopsies. The biopsies are reviewed and evaluated by two independent pathologists, experienced in colonic pathology, concerning morphological changes, dysplasia and potential carcinoma Results Architectural structural changes, inflammation and reactive atypia is noted in the rectal cuff and ileal pouch. So far, none of the biopsies showed genuine dysplasia after a follow up for 18 years (Range 12-23 years). In this respect there is full agreement between the two pathologists.

Further microscopic evaluation are planned for the rest of the participating patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Critical Assessment of Routine Surveillance of Asymptomatic Patients With Ulcerative Colitis With Ileal Pouch-anal Anastomosis and Risk Factors for Dysplasia - is There a Rationale?
Study Start Date :
Feb 1, 2010
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Feb 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: Endoscopy and biopsy

Endoscopy with biopsy taken Endoscopy and biopsy Blood samples Questionnaire

Procedure: Endoscopy and biopsy
Endoscopy with biopsy of the ileo-anal pouch and the ileo-anal anastomosis Blood samples

Outcome Measures

Primary Outcome Measures

  1. Presence of dysplasia in patients with Ulcerative Colitis and Ileal Pouch-Anal Anastomosis [Up to 7 days]

    The study ends at above mentioned date. After that, microscopic evaluation, statistics and analysis will be done.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • UC (Ulcerative Colitis)

  • IPAA

  • risk factor for dysplasia

Exclusion Criteria:
  • Not able to give consent

  • CD (Crohns disease)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Surgery, Inst for Clinical Sciences, Sahlgrenska University Hospital Göteborg Sweden 41685

Sponsors and Collaborators

  • Mattias Block

Investigators

  • Study Chair: Lars Börjesson, Surgeon, Department of Surgery, Sahlgrenska, Göteborg

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mattias Block, Doctor, Surgeon, MD, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT01764542
Other Study ID Numbers:
  • GLS-249941
First Posted:
Jan 9, 2013
Last Update Posted:
Apr 19, 2016
Last Verified:
Apr 1, 2016
Keywords provided by Mattias Block, Doctor, Surgeon, MD, Sahlgrenska University Hospital, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2016